Home Applications 020873 Application 020873
Type NDA
Sponsor SANDOZ INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 ANGIOMAX BIVALIRUDIN INJECTABLE;INTRAVENOUS 250MG/VIAL Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020873-001 ANGIOMAX BIVALIRUDIN 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N020873-001 AP
Orange Book patents# Current patent rows page 1 of 1 · 4 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N020873-001 7582727 2028-07-27 Drug product N020873-001 7598343 2028-07-27 Drug product N020873-001 7582727*PED 2029-01-27 Pediatric extension N020873-001 7598343*PED 2029-01-27 Pediatric extension
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N020873-001 ANGIOMAX 250MG/VIAL INJECTABLE / INTRAVENOUS AP RLD, RS 2000-12-15 cb3db0bc1861…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
Observed Orange Book patent history# Patent history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N020873-001 7582727 2028-07-27 Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020873-001 7598343 2028-07-27 Drug product 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020873-001 7582727*PED 2029-01-27 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020873-001 7598343*PED 2029-01-27 Pediatric extension 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020873-001 7582727 2028-07-27 Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020873-001 7598343 2028-07-27 Drug product 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020873-001 7582727*PED 2029-01-27 Pediatric extension 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020873-001 7598343*PED 2029-01-27 Pediatric extension 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020873-001 7582727 2028-07-27 Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020873-001 7598343 2028-07-27 Drug product 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020873-001 7582727*PED 2029-01-27 Pediatric extension 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020873-001 7598343*PED 2029-01-27 Pediatric extension 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020873-001 7582727 2028-07-27 Drug product fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020873-001 7598343 2028-07-27 Drug product fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020873-001 7582727*PED 2029-01-27 Pediatric extension fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020873-001 7598343*PED 2029-01-27 Pediatric extension fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020873-001 7582727 2028-07-27 Drug product b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020873-001 7598343 2028-07-27 Drug product b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020873-001 7582727*PED 2029-01-27 Pediatric extension b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020873-001 7598343*PED 2029-01-27 Pediatric extension b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020873-001 7582727 2028-07-27 Drug product 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020873-001 7598343 2028-07-27 Drug product 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020873-001 7582727*PED 2029-01-27 Pediatric extension 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020873-001 7598343*PED 2029-01-27 Pediatric extension 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020873-001 7582727 2028-07-27 Drug product 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020873-001 7598343 2028-07-27 Drug product 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020873-001 7582727*PED 2029-01-27 Pediatric extension 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020873-001 7598343*PED 2029-01-27 Pediatric extension 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020873-001 7582727 2028-07-27 Drug product 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020873-001 7598343 2028-07-27 Drug product 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020873-001 7582727*PED 2029-01-27 Pediatric extension 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020873-001 7598343*PED 2029-01-27 Pediatric extension 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020873-001 7582727 2028-07-27 Drug product d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020873-001 7598343 2028-07-27 Drug product d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020873-001 7582727*PED 2029-01-27 Pediatric extension d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020873-001 7598343*PED 2029-01-27 Pediatric extension d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N020873-001 7582727 2028-07-27 Drug product d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020873-001 7598343 2028-07-27 Drug product d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020873-001 7582727*PED 2029-01-27 Pediatric extension d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020873-001 7598343*PED 2029-01-27 Pediatric extension d06236e962d9…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 10 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0781-3158 bivalirudin bivalirudin Sandoz NDA AUTHORIZED GENERIC Current 0781-3158 bivalirudin bivalirudin Sandoz Inc NDA AUTHORIZED GENERIC Current 0781-3447 Angiomax bivalirudin Sandoz Inc NDA Current 0781-3447 Angiomax bivalirudin Sandoz Inc NDA Current 0781-9158 bivalirudin bivalirudin Sandoz Inc NDA AUTHORIZED GENERIC Current 0781-9158 bivalirudin bivalirudin Sandoz NDA AUTHORIZED GENERIC Current 65293-001 Angiomax bivalirudin The Medicines Company NDA Current 65293-001 Angiomax bivalirudin The Medicines Company NDA Current 65293-001 Angiomax bivalirudin The Medicines Company NDA Current 72572-035 bivalirudin bivalirudin Civica, Inc. NDA AUTHORIZED GENERIC Current